Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published October 15, 2019

Viatrexx-Hair Recall: Lack of Sterility Assurance in Rx Vials

Viatrexx recalls Viatrexx-Hair 10 mL vials due to sterility concerns. Check lot numbers and expiration dates for affected products distributed to physicians.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0345-2020DrugViatrexx ›
Take action

Contact the company

Recalling firm8046255 Canada Inc. DBA Viatrexx1360 Louis-Marchand St · Beloeil, Canada
✎ GovInfoNow plain-language explainer

8046255 Canada Inc. DBA Viatrexx is recalling Viatrexx-Hair, a 10 mL sterile multi-dose vial prescribed for hair treatment. The recall is necessary because the manufacturing process cannot guarantee the product's sterility. Only three vials were distributed to physicians nationwide. Read more at govinfonow.com/recall/37835-viatrexx-hair-recall-lack-of-sterility-assurance-in-rx-vials.

Source Summary by GovInfoNow · govinfonow.com/recall/37835-viatrexx-hair-recall-lack-of-sterility-assurance-in-rx-vials · Updated October 11, 2026 · FDA enforcement record: FDA #D-0345-2020

Cite this page

“Viatrexx-Hair Recall: Lack of Sterility Assurance in Rx Vials.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37835-viatrexx-hair-recall-lack-of-sterility-assurance-in-rx-vials. Based on FDA recall #D-0345-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0345-2020%22&limit=1).

8046255 Canada Inc. DBA Viatrexx recalled Viatrexx-Hair sterile multi-dose vials due to a lack of assurance of sterility, according to the FDA. The agency announced the Class II recall on October 15, 2019.

How to tell if you have it

  • Brand: Viatrexx
  • Product: Viatrexx-Hair Sterile Vial
  • Item: VSPC0251
  • NDC: 73069-206-41
  • Lot Numbers: 19-S00009
  • Quantity: 3 vials

The hazard

The products were manufactured in a manner that cannot guarantee sterility. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show the brand has been involved in other recent recalls of similar products, including Reliance Pemetrexed Injection Recall: Sterility Risk in IV Doses (2026-06-24) and Reliance Pemetrexed Injection Recall: Lack of Sterility Risk (2026-06-24). Other recent recalls of similar products include Cipla Lanreotide Injection Recall: Risk of Contamination Due to Sterility Issues (2026-03-13).

How to tell if you have this one

Look for Viatrexx-Hair, 10 mL Sterile multi-dose vial, Rx only. The specific item is VSPC0251 with NDC 73069-206-41. Affected lot numbers are 19-S00009.

  • Brand
    Viatrexx
  • Category
    Drug
FDA recall event · 23 products

All 23 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Recall numberProduct, codes & lotsQuantity
D-0326-2020Viatrexx-Connectissue, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0090, NDC 73069-100-41.; Lot Numbers: 19-S00001, Exp. May: 202024 vials
D-0327-2020Viatrexx-MuSkel-Neural, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC4020, NDC 73069-347-41.; Lot Numbers: 19-S00002, Exp. May: 202061 vials
D-0328-2020Viatrexx-Ouch, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0500, NDC 73069-402-41.; Lot Numbers: 19-S00003, Exp. May: 202019 vials
D-0329-2020Viatrexx-Ithurts, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0290, NDC 73069-270-41.; Lot Numbers: 19-S00004, Exp. May: 202012 vials
D-0330-2020Viatrexx-Adipose, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0008, NDC 73069-024-41.; Lot Numbers: 19-S00005, Exp. May: 20204 vials
D-0331-2020Viatrexx-Systemic Detox, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0665, NDC 73069-500-41.; Lot Numbers: 19-S00007, Exp. May: 20205 vials
D-0332-2020Viatrexx-Articula, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0031, NDC 73069-037-41.; Lot Numbers: 19-S00008, Exp. May: 202069 vials
D-0333-2020Viatrexx-Neuro 3, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0463, NDC 73069-373-41.; Lot Numbers: 19-S00010, Exp. May: 20207 vials
D-0334-2020Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41.; Lot Numbers: 19-S00012, Exp. May: 202054 vials
D-0335-2020Viatrexx-Collagen, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0085, NDC 73069-095-41.; Lot Numbers: 19-S00014, Exp. May: 202022 vials
D-0336-2020Viatrexx-Prolo, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0558, NDC 73069-443-41.; Lot Numbers: 19-S00016, Exp. May: 202042 vials
D-0337-2020Viatrexx-Lymph 1, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0370, NDC 73069-310-41.; Lot Numbers: 19-S00017, Exp. May: 20203 vials
D-0338-2020Viatrexx-Mesenchyme, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0092, NDC 73069-102-41.; Lot Numbers: 19-S00018, Exp. May: 20207 vials
D-0339-2020Viatrexx-GI, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0211, NDC 73069-189-41.; Lot Numbers: 19-S00019, Exp. May: 20203 vials
D-0340-2020Viatrexx-Arthros, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0030, NDC 73069-035-41.; Lot Numbers: 19-S00021, Exp. May: 20206 vials
D-0341-2020Viatrexx-Immunexx, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0270, NDC 73069-244-41.; Lot Numbers: 19-S00023, Exp. May: 202018 vials
D-0342-2020Viatrexx-Relief +, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0615, NDC 73069-450-41.; Lot Numbers: 19-S00024, Exp. May: 20201 vial
D-0343-2020Viatrexx-Intra-Cell, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0280, NDC 73069-250-41.; Lot Numbers: 19-S00025, Exp. May: 20208 vials
D-0344-2020Viatrexx-Facial, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0184, NDC 73069-164-41.; Lot Numbers: 19-S00026, Exp. May: 202013 vials
D-0345-2020Viatrexx-Hair, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0251, NDC 73069-206-41.; Lot Numbers: 19-S00009, Exp. May: 20203 vials
D-0346-2020Viatrexx-Neuro, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0460, NDC 73069-375-41.; Lot Numbers: 19-S00020, Exp. May: 202013 vials
D-0347-2020Viatrexx-Male+, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0400, NDC 73069-320-41.; Lot Numbers: 19-S00022, Exp. May: 20202 vials
D-0348-2020Viatrexx-ANS/CNS, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0025, NDC 73069-039-41.; Lot Numbers: 19-S00027, Exp. May: 20201 vial
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Physicians should immediately stop using any recalled Viatrexx-Hair vials to prevent potential infection risks.

  2. Contact Manufacturer for Instructions

    Since the remedy is not stated in the record, contact 8046255 Canada Inc. DBA Viatrexx directly for specific return or disposal instructions.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Distributed to physicians Nationwide throughout the United States and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Oct 15, 201912. FDA classified it Class II: Nov 14, 201923. Published in FDA’s Enforcement Report: Nov 20, 201934. FDA terminated the recall: Dec 10, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0345-2020 (October 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0345-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA